Abstract: A composition for use on skin and wounds, comprising a photo-catalyst which is capable of preferentially staining biofilms the composition being for use in the diagnosis and treatment of biofilms in wounds.

Abstract: Process for treating a catalytic reactor comprising a catalyst bed that includes the successive steps of passivating the catalytic reactor leading to the production of an oxidation layer at the surface of the active sites of the catalyst bed, opening the reactor, and skimming at least one portion of the catalyst bed.

Abstract: The invention relates to a method for decreasing the spread of the tube temperatures between tubes in a process involving the heating of at least one fluid in a furnace that comprises at least one radiation chamber with radiant walls, at least one essentially vertical row of tubes inside of which circulate the at least one fluid to be heated, and being equipped with burners that heat the tubes, where the method comprises the steps of: determining, for each of the tubes the skin temperature of the tube, selecting the 50% tubes having the lowest temperatures determined, the process being stopped, realizing on each tube selected an operation that decreases the flow of the fluid distributed to said tube while keeping the total flow rate of the fluid unchanged.

Abstract: Process for treating a catalytic reactor comprising a catalyst bed that includes the successive steps of passivating the catalytic reactor leading to the production of an oxidation layer at the surface of the active sites of the catalyst bed, opening the reactor, and skimming at least one portion of the catalyst bed.

Abstract: A device is provided. The device has an arcuate guide disposed about a shoe. The guide has a start point on an inner side of the shoe, an intermediate point on a heel side of the shoe, and an end point on an outer side of the shoe. The guide is angled upward across the heel side from the inner side to the outer side with the angle in a range between about 30 degrees to about 60 degrees. The start point and end point are positioned on the shoe at a point lower than the intermediate point. The device also has an indicator moveable along the guide. The indicator is an alert to the user of the device that the user has executed proper body motions during a swing or throw, when the indicator traverses from the start point through the intermediate point to the end point. Also provided is a system and method.

Abstract: The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the group consisting of poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, methyl methacrylate) 1:1, and mixtures thereof; and c. an outer coating layer comprising an enteric polymer or film coating material; wherein the inner coating layer is not the same as the outer coating layer; wherein if the inner coating layer is poly(methacrylic acid, methyl methacrylate) 1:1 then the outer coating layer is not poly(methacrylic acid, methyl methacrylate) 1:2 or is not a mixture of poly(methacrylic acid, methyl methacrylate) 1:1 and poly(methacrylic acid, methyl methacrylate) 1:2; and wherein the inner coating layer and the outer coating layer do not contain any therapeutically active agent.

Abstract: The invention relates to a catalytic reactor including: at least one first architecture/microstructure including a ceramic and/or metal cellular architecture having a pore size of 2 to 80 ppi and a macroporosity of more than 85%, and a microstructure having a grain size of 100 nm to 5 microns, and skeleton densification of more than 95%, and a catalytic layer; and at least one second architecture/microstructure including a spherical or cylindrical architecture having a pore size of 0.1 to 100 ?m and a macroporosity of less than 60%, and a microstructure having a grain size of 20 nm to 10 ?m and a skeleton densification of 20% to 90%, and a catalytic layer; the first and second architecture/microstructure being stacked inside said reactor.

Abstract: The invention relates to a method for decreasing the spread of the tube temperatures between tubes in a process involving the heating of at least one fluid in a furnace that comprises at least one radiation chamber with radiant walls, at least one essentially vertical row of tubes inside of which circulate the at least one fluid to be heated, and being equipped with burners that heat the tubes, where the method comprises the steps of: determining, for each of the tubes the skin temperature of the tube, selecting the 50% tubes having the lowest temperatures determined, the process being stopped, realizing on each tube selected an operation that decreases the flow of the fluid distributed to said tube while keeping the total flow rate of the fluid unchanged.

Abstract: [RhxMgyAlw(OH)2](3x+2y+3w?2)+(A2?)(3x+2y+3w?2)/2,k H2) (I) Hydrotalcite-like compound of the formula (I): catalyst synthesis process involving such a compound, and the use of this catalyst for hydrocarbons reforming and for ethanol reforming.

Abstract: A hydrotalcite-type compound of the formula (I): [CuxZnyAlw(OH)2](2x+2y+3w?2)+(A2?)(2x+2y+3w?2)/n,kH2O??(I) wherein (A2?) represents either a carbonate anion or a silicate anion, x>0, y>0, w>0, (x+y)=(1?w), 1<[(x+y)/w]<5, and 1/99?x/y?1/1; a synthesis process for its preparation; a catalyst obtained by its calcination and the subsequent reduction of the calcined product.

Abstract: A method for purifying an argon stream is provided. The method includes pretreating an argon waste stream to remove impurities to provide a pre-treated argon waste stream having argon, nitrogen, and hydrogen; cooling the argon waste stream to create a cold feed stream; and condensing the cold feed stream to create a liquid feed stream. The liquid feed stream is fed to the cryogenic distillation column to create a bottoms argon product stream and a gas waste stream. The bottoms argon product stream travels to an expansion device to provide a cooled bottoms argon product stream, which can optionally be combined with an argon lift stream downstream of the expansion device. The combined argon lift stream and cooled bottoms argon product stream are fed to the overhead condenser and vaporized to create a purified vapor phase argon stream.

Abstract: An argon purification system is provided which includes a cryogenic heat exchanger, a cryogenic distillation column. The cryogenic heat exchanger is configured to remove heat from a pre-treated argon waste stream to create a cold feed stream. The cryogenic distillation column includes packing, a reboiler, and an overhead condenser, as well as an upper portion and a lower portion and is configured to receive a liquid feed stream and to produce a bottoms argon product stream and a gas waste stream. The reboiler is positioned in the lower portion of the cryogenic distillation column and is configured to condense the cold feed stream to produce the liquid feed stream. The condenser is positioned in the upper portion of the cryogenic distillation column and is configured to heat the bottoms argon product stream such that the bottoms argon product stream evaporates to a purified vapor phase argon stream.

Abstract: A staining composition for use in making biofilm detectable on viable tissue wherein the composition preferentially stains the biofilm and comprises a staining agent in a quantity effective to stain said biofilm and render it detectable.

Abstract: The invention relates to a catalytic reactor including: a reaction chamber; at least one catalytic structure made up of at least one catalytic cell-like architecture having outer dimensions at most 10% smaller than the inner dimensions of the reaction chamber; an annular space between the inner wall of the reaction chamber and the cell-like architectures; and at least one second structure positioned in the annular space, selected from among: a) a fibrous structure, or b) a structure including at least one metal collar clasping at least one portion of the cell-like architectures and supporting metal fins.

Abstract: The present invention a catalyst that includes a metallic or ceramic foam catalyst support having surfaces within the foam for the placement of a catalytic material, and an active catalyst material which is applied by washcoating or dipping.

Abstract: The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the group consisting of poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, methyl methacrylate) 1:1, and mixtures thereof; and c. an outer coating layer comprising an enteric polymer or film coating material; wherein the inner coating layer is not the same as the outer coating layer; wherein if the inner coating layer is poly(methacrylic acid, methyl methacrylate) 1:1 then the outer coating layer is not poly(methacrylic acid, methyl methacrylate) 1:2 or is not a mixture of poly(methacrylic acid, methyl methacrylate) 1:1 and poly(methacrylic acid, methyl methacrylate) 1:2; and wherein the inner coating layer and the outer coating layer do not contain any therapeutically active agent.

Abstract: The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the group consisting of poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, methyl methacrylate) 1:1, and mixtures thereof; and c. an outer coating layer comprising an enteric polymer or film coating material; wherein the inner coating layer is not the same as the outer coating layer; wherein if the inner coating layer is poly(methacrylic acid, methyl methacrylate) 1:1 then the outer coating layer is not poly(methacrylic acid, methyl methacrylate) 1:2 or is not a mixture of poly(methacrylic acid, methyl methacrylate) 1:1 and poly(methacrylic acid, methyl methacrylate) 1:2; and wherein the inner coating layer and the outer coating layer do not contain any therapeutically active agent.

Abstract: The invention concerns in particular a method for purifying an input mixture comprising carbon dioxide (CO<SUB>2</SUB>) and carbon monoxide (CO), to eliminate the carbon monoxide contained in said mixture, which consists in contacting, at a temperature higher than room temperature, the input mixture with a purifying material comprising at least one metal oxide, so as to bring about the reduction of the purifying material by the input mixture, leading to oxidization of at least part of the CO of the input mixture into CO<SUB>2</SUB>. The invention also concerns a gaseous chilling method and installation integrating such a purifying operation.

Abstract: The invention relates to a catalytic reactor including at least two catalytic cellular architectures and at least one structural element, inserted between the two catalytic cellular architectures, in which the entire outer perimeter is in contact with the inner wall of the reactor, the cellular architecture and the structural element being arranged coaxially.

Abstract: The invention relates to a catalytic reactor including: at least one first architecture/microstructure including a ceramic and/or metal cellular architecture having a pore size of 2 to 80 ppi and a macroporosity of more than 85%, and a microstructure having a grain size of 100 nm to 5 microns, and skeleton densification of more than 95%, and a catalytic layer; and at least one second architecture/microstructure including a spherical or cylindrical architecture having a pore size of 0.1 to 100 ?m and a macroporosity of less than 60%, and a microstructure having a grain size of 20 nm to 10 ?m and a skeleton densification of 20% to 90%, and a catalytic layer; the first and second architecture/microstructure being stacked inside said reactor.